Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab Continuation Study in SLE (US)
NCT00724867Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2008
- Primary completion
- Mar 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by GSK. Started Aug 2008; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00724867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00724867.